Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedJun 14, 2017Estradiol 12.5 mg pellet 99.5% Estradiol USPCGMP deviations- Lack of Quality AssuranceQualgen · D-0894-2017Class IITerminatedJun 14, 2017Estradiol 15 mg pellet 99.5% Estradiol USPCGMP deviations- Lack of Quality AssuranceQualgen · D-0893-2017Class IITerminatedJun 14, 2017Estradiol 18 mg pelletCGMP deviations- Lack of Quality AssuranceQualgen · D-0892-2017Class IITerminatedJun 14, 2017Estradiol 20 mg pellet 99.5% Estradiol USPCGMP deviations- Lack of Quality AssuranceQualgen · D-0891-2017Class IITerminatedJun 14, 2017Estradiol 22 mg pellet 99.5% Estradiol USPCGMP deviations- Lack of Quality AssuranceQualgen · D-0890-2017Class IITerminatedJun 14, 2017Estradiol 25 mg pellet 99.5% Estradiol USPCGMP deviations- Lack of Quality AssuranceQualgen · D-0889-2017Class IITerminatedJun 14, 2017methylcobalamin 1mg/1mLLack of Assurance of SterilityMedPark Pharmacy, LLC · D-0888-2017Class IITerminatedJun 14, 2017Option 2Defective Container: Carton is missing the tablet blister strip and tablet.L. Perrigo Company · D-0887-2017Class IITerminatedJun 14, 2017ZenataneFailed Dissolution Specifications: out of specification results observed for low dissolution.Dr. Reddy's Laboratories, Inc. · D-0886-2017Class IITerminatedJun 14, 2017ZenataneFailed Dissolution Specifications: out of specification results observed for low dissolution.Dr. Reddy's Laboratories, Inc. · D-0885-2017Class IITerminatedJun 14, 2017ZenataneFailed Dissolution Specifications: out of specification results observed for low dissolution.Dr. Reddy's Laboratories, Inc. · D-0884-2017Class IITerminatedJun 14, 2017ZenataneFailed Dissolution Specifications: out of specification results observed for low dissolution.Dr. Reddy's Laboratories, Inc. · D-0883-2017Class IITerminatedJun 14, 2017LevonorgestrelCGMP Deviations: these repackaged and redistributed products are being recalled due to a recall notice from the active pharmaceutical ingredient manufacturer for...Spectrum Laboratory Products, Inc. · D-0882-2017Class IITerminatedJun 14, 2017EstradiolCGMP Deviations: these repackaged and redistributed products are being recalled due to a recall notice from the active pharmaceutical ingredient manufacturer for...Spectrum Laboratory Products, Inc. · D-0881-2017Class IITerminatedJun 7, 2017Saphris 10 mgLabeling; Label Mixup; blister lidding foil and shell-pack labeled as 10 mg but package actually contains 5 mg tabletsForest Laboratories, LLC · D-0880-2017Class IITerminatedJun 7, 2017PHENYLephrine HCL in 0.9% Sodium Chloride injectableLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0879-2017Class IITerminatedJun 7, 2017MAGNESIUM Sulfate added to 100 mL 0.9% Sodium Chloride injectableLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0878-2017Class IITerminatedJun 7, 2017ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectableLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0877-2017Class IITerminatedJun 7, 2017ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectableLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0876-2017Class IITerminatedJun 7, 2017HYDROmorphone HCL in 0.9% Sodium Chloride injectableLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0875-2017Class IITerminatedJun 7, 2017fentaNYLLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0874-2017Class IITerminatedJun 7, 2017fentaNYLLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0873-2017Class IITerminatedJun 7, 2017fentaNYLLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0872-2017Class IITerminatedJun 7, 2017morphine sulfate in 0.9% Sodium Chloride injectableLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0871-2017Class IITerminatedJun 7, 2017morphine sulfate in 0.9% Sodium Chloride injectableLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0870-2017Class IIITerminatedJun 7, 2017Nystatin Oral SuspensionFailed Impurities/Degradation Specifications: Presence of an impurity peak that exceeds approved specification.VistaPharm, Inc. · D-0869-2017Class IIITerminatedJun 7, 2017Amoxicillin and Clavulanate Potassium TabletsSubpotent Drug; Clavulanic AcidSandoz Inc · D-0868-2017Class ITerminatedMay 31, 2017LaBri's Body Health AtomicMarketed without an approved NDA/ANDA: Product contains undeclared Sibutramine.Envy Me · D-0867-2017Class IITerminatedMay 31, 2017Shield and Protect Moisture Barrier CreamGMP Deviations; product may not meet cGMP requirementsGentell, Inc · D-0866-2017Class IITerminatedMay 31, 2017Refresh TearsLabeling: Not elsewhere classified; product labeling lacks a NDC number, net weight information and does not contain the Drug Facts Panel.Cell Distributors · D-0865-2017Class ITerminatedMay 31, 2017Hyland's Baby Nighttime Teething Tablets [Belladonna 12X HPUSSuperpotent Drug: FDA analysis found inconsistent amounts of belladonna alkaloids that may differ from the calculated amount on the product labels.Standard Homeopathic Company · D-0864-2017Class ITerminatedMay 31, 2017Hyland's Baby Teething Tablets [Calcarea Phosporica 6X HPUSSuperpotent Drug: FDA analysis found inconsistent amounts of belladonna alkaloids that may differ from the calculated amount on the product labels.Standard Homeopathic Company · D-0863-2017Class IOngoingMay 31, 2017Infant 25% DEXTROSE InjectionPresence of Particulate Matter: human hair found within an internal sample syringe.Hospira Inc. · D-0862-2017Class IIITerminatedMay 31, 2017Norethindrone Acetate and Ethinyl Estradiol TabletsChemical Contamination: out of specification results for impurities were found to be the result of contamination of product from vapors associated with paint thinner...Mylan Pharmaceuticals Inc. · D-0861-2017Class IIITerminatedMay 31, 2017Tarina Fe 1/20Chemical Contamination: out of specification results for impurities were found to be the result of contamination of product from vapors associated with paint thinner...Mylan Pharmaceuticals Inc. · D-0860-2017Class IIITerminatedMay 31, 2017HYDROCORTISONE LOTIONSuperpotent Drug: above specification for the assay.Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals · D-0859-2017Class IIITerminatedMay 31, 2017Benzonatate capsulesFailed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.Strides Pharma INC · D-0858-2017Class IIITerminatedMay 31, 2017Children's Cetirizine Hydrochloride Chewable TabletsFailed Tablet/Capsule Specifications: out of specification results for increased tablet hardness.Sun Pharmaceutical Industries, Inc. · D-0857-2017Class IITerminatedMay 31, 2017DORAMA-NEOLack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.Sato Pharmaceutical Inc. · D-0856-2017Class IITerminatedMay 31, 2017SATO CLEARLack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.Sato Pharmaceutical Inc. · D-0855-2017